[1]夏金超,汪勇锋,许岗勤,等.不同类型支架治疗椎动脉开口狭窄的对照研究[J].介入放射学杂志,2020,29(02):136-139.
 XIA Jinchao,WANG Yongfeng,XU Gangqin,et al.The effect and safety of different types of stents in treating vertebral artery origin stenosis: a control study[J].journal interventional radiology,2020,29(02):136-139.
点击复制

不同类型支架治疗椎动脉开口狭窄的对照研究()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
29
期数:
2020年02
页码:
136-139
栏目:
神经介入
出版日期:
2020-03-14

文章信息/Info

Title:
The effect and safety of different types of stents in treating vertebral artery origin stenosis: a control study
作者:
夏金超汪勇锋许岗勤薛降宇白卫星朱良付王子亮
Author(s):
XIA Jinchao WANG Yongfeng XU Gangqin XUE Jiangyu BAI Weixing ZHU Liangfu WANG Ziliang.
Department of Cerebrovascular Diseases, Henan Provincial People’s Hospital, People’s Hospital of Zhengzhou University, Zhengzhou, Henan Province 450003, China
关键词:
【关键词】 药物洗脱支架金属裸支架椎动脉开口狭窄再狭窄
文献标志码:
A
摘要:
【摘要】 目的?比较不同类型支架治疗椎动脉开口狭窄的有效性和安全性。方法?2018年1月至2018年12月73例椎动脉开口狭窄患者共86条病变血管接受支架成形术治疗,分别应用肾动脉支架23枚,Apollo支架26枚,冠状动脉裸支架19枚,药物洗脱支架(DES)18枚。回顾性分析患者临床资料,对比不同类型支架植入术疗效和支架内再狭窄发生率。结果?不同类型椎动脉开口支架成形术均获成功。术前影像显示椎动脉开口平均狭窄率为90.9%,术后即刻影像显示平均残余狭窄率为10.3%。围术期手术相关并发症发生率为1.2%(1/86)。术后平均随访(6.2±3.1)个月,患者临床症状得到改善。肾动脉枚架失访1枚,再发狭窄4枚(17%);Apollo枚架失访2枚,再发狭窄8枚(31%),1例患者术后第2日并发大面积后循环脑梗死;冠状动脉裸枚架无失访,再狭窄7枚(37%),1例患者6个月时枚架断裂;DES组失访1枚,再狭窄2枚(11%),与其他组再发狭窄差异有统计学意义(P<0.05)。结论?不同类型枚架治疗椎动脉狭窄安全有效。DES在降低枚架内再狭窄发生方面最优,肾动脉枚架次之,Apollo枚架和冠状动脉裸枚架再狭窄率较高。

参考文献/References:

[1] Rangel-Castilla L, Kalani MY, Cronk K, et al. Vertebral for revascularization of the posterior circulation: a critical assessment of temporary and permanent complications and outcomes[J]. Neurosurg, 2015, 122: 671-677.
[2] Aaron N, Stayman MD, Raul G, et al. A systematic review of stenting and angioplasty of symptomatic extracranial vertebral artery Stenosis[J]. Stroke, 2011, 42: 2212-2216.
[3] Thompson MC, Issa MA, Lazzaro MA, et a1.The natural history of vertebral artery origin stenosis[J].J Stroke Cerebrovasc Dis, 2014, 23: el-e4.
[4] Tank VH, Ghosh R, Gupta V, et al. Drug eluting stents versus bare metal stents for the treatment of extracranial vertebral artery disease: a meta-analysis[J]. Neurointerv Surg, 2016, 8: 770-774.
[5] Stayman AN, Nogueira RG, Gupta R. A systematic review of stenting and angioplasty of symptomatic extracranial vertebral artery stenosis[J]. Stroke, 2011, 42: 2212-2216.
[6] Maciejewski D, Tekieli L, Kab?ak-Ziembicka A, et al. Transradial approach for vertebral artery stenting[J].Postep Kardiol Inter, 2015, 11: 32-36.
[7] Langwieser N, Buyer D, Schuster T, et al. Bare metal vs. drug-eluting stents for extracranial vertebral artery disease: a meta-analysis of nonrandomized comparative studiesl[J]. J Endovasc Ther, 2014, 21: 683-692.
[8] Lu H, Zheng P, Zhang W. Long-term outcome of drug-eluting stenting for stenoses of the intracranial vertebrobasilar artery and vertebral ostiums[J]. Neurointerv Surg, 2013, 5: 435-439.
[9] 赵同源, 李钊硕, 薛降宇, 等.药物洗脱支架与金属裸支架治疗椎动脉开口狭窄的对照研究[J]. 中华神经医学杂志, 2015, 14:506-510.
[10] Maciejewski DR, Tekieli L, Machnik R, et a1.Simultaneous vertebral and subclavian artery stenting[J]. Postepy Kardiol Interwencyjnej, 2017, 13: 142-149.
[11] Rangel-Castilla L, Gandhi S, Munich SA, et al.Experience with vertebral artery origin stenting and ostium dilatation: results of treatment and clinical outcomes[J]. J Neurointerv Surg, 2016, 8: 476-480.
[12] Chen ZY, Li M, Li MH, et al. Expansive arterial remodeling of carotid arteries in symptomatic ischemic patients[J]. J Intervent Med, 2018, 1: 82-85.
[13] Chen X, Huang Q, Hong B, et al. Drug-eluting stent for the treatment of symptomatic vertebral origin stenosis: long-term results[J]. Clin Neurosci, 2011, 18: 47-51.

备注/Memo

备注/Memo:
(收稿日期:2019-04-14)
(本文编辑:边?佶)
更新日期/Last Update: 2020-03-13